MedTrace Logo

Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected Women

NCT02949713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2023-09-26

No results posted yet for this study

Summary

The primary aim of this study is to find out whether it is feasible to conduct a larger study looking at the effect of mobile phone text messaging added to motivational interviewing on number of participants invited to the study who consented to participate and the number with complete evaluation of infant feeding practices at all study visits.

Secondary aim: In HIV-infected women initiating breastfeeding after giving birth, does interactive weekly mobile phone text messaging plus motivational interviewing versus usual care, improve self-reported adherence to exclusive or any breastfeeding 6 months post-delivery and to determine the number of women remaining in the group they were assigned until end of study or lost to follow-up (protocol adherence).

Conditions

  • HIV Infections
  • Breast Feeding

Interventions

BEHAVIORAL

Text messaging-motivational interviewing

Interactive weekly mobile phone text messaging plus prospective motivational interviews

Sponsors & Collaborators

  • McMaster University

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • University of Stellenbosch

    lead OTHER

Principal Investigators

  • Moleen Zunza · University of Stellenbosch

  • Taryn Young · University of Stellenbosch

  • Mark F Cotton · University of Stellenbosch

  • Lehana Thabane · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2020-08-13
Completion
2020-08-13

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02949713 on ClinicalTrials.gov